Sort
15,842 grants matching “pancreatic cancer”
Cancer Immunotherapy Clinical Trials
$1,168,320Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Integrative Molecular Profiling of Human Pancreatic Cancer
$1,168,220Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer
$1,168,220Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Retroviral genetic modification of PBLs to optimize expansion for cell therapy
$1,166,802Nicholas Klemen · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
TASK ORDER TITLE: EVALUATION OF REAL-TIME METABOLIC IMAGING BIOMARKERS FOR DETECTION OF PANCREATIC PREMALIGNANT LESIONS
$1,166,274Powell Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2021 · CA
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,165,814Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
UCLA Center for Excellence in Pancreatic Diseases
$1,164,484Vay Liang W. Go · University Of California Los Angeles · P01 · FY2007 · AT
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,163,016Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,162,978Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2016 · CA
Center for digestive and liver diseases
$1,162,114Anil K Rustgi · University Of Pennsylvania · P30 · FY2011 · DK
Targeting pancreatic cancer metastases with Targefrin
$1,162,000Carlo Baggio · Armida Labs, Inc. · R44 · FY2025 · CA
Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images
$1,160,586Debiao Li · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
$1,159,739Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2020 · CA
MOLECULAR BIOMARKERS
$1,158,819Massachusetts Institute Of Technology · P01 · FY2000 · ES
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy
$1,156,734Amanda M Schalk · Enzyme By Design, Inc. · R44 · FY2020 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$1,155,055Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Histidine phosphorylation as a new target for cancer therapy
$1,154,400Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2025 · CA
Histidine phosphorylation as a new target for cancer therapy
$1,154,400Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2020 · CA
Histidine phosphorylation as a new target for cancer therapy
$1,154,400Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2022 · CA
Histidine phosphorylation as a new target for cancer therapy
$1,153,906Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2021 · CA
Cellular In vivo Imaging
$1,153,574Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
$1,152,768Michael Karin · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2025 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,151,937Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,151,039Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Preclinical drug development in pancreatic cancer
$1,150,996Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA